784 related articles for article (PubMed ID: 14700170)
21. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
22. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
[TBL] [Abstract][Full Text] [Related]
23. [Seroepidemiology of measles in Mexico].
Sepúlveda J; Tapia-Conyer R; Valdespino JL; Quiroz G; Salvatierra B; Zárate ML; Magos C; Llausás A; Gutiérrez G
Salud Publica Mex; 1992; 34(2):148-56. PubMed ID: 1631729
[TBL] [Abstract][Full Text] [Related]
24. Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines.
Rosen JB; Breman JG; Manclark CR; Meade BD; Collins WE; Lobel HO; Saliou P; Roberts JM; Campaoré P; Miller MA
Malar J; 2005 Nov; 4():53. PubMed ID: 16271153
[TBL] [Abstract][Full Text] [Related]
25. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy of three measles vaccines in Indian children.
Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
[TBL] [Abstract][Full Text] [Related]
27. Measles antibody in the children in Ubon Ratchathani province.
Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
[TBL] [Abstract][Full Text] [Related]
28. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
[TBL] [Abstract][Full Text] [Related]
29. Measles immunization status in 1972 among first- and second-grade school children in Danbury, Connecticut.
Lepow ML; Steele FM; Ross MR; Randolph MF
Pediatrics; 1975 Mar; 55(3):348-53. PubMed ID: 806881
[TBL] [Abstract][Full Text] [Related]
30. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
[TBL] [Abstract][Full Text] [Related]
31. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P
Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
33. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
34. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
[TBL] [Abstract][Full Text] [Related]
35. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
36. [Study on the neutralization capacity of different types of human measles virus vaccine and the epidemic strains].
Feng Y; Lu YY; Yan JY; Jiang XH; Shi W; Xu CP; Li Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1123-6. PubMed ID: 18396671
[TBL] [Abstract][Full Text] [Related]
37. [Immunization of hepatitis B vaccine integrated with expanded program on immunization schedule in children].
Huang J
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):1-4. PubMed ID: 1581948
[TBL] [Abstract][Full Text] [Related]
38. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
Egami T; Egami K; Tanoue A
Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):282-94. PubMed ID: 19323013
[TBL] [Abstract][Full Text] [Related]
40. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
